Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 10, 1996, Pages 2099-2109

  Takagi, Chikako ^a   King, George L ^a   Takagi, Hitoshi ^a   Lin, You Wei ^a   Clermont, Allen C ^a   Bursell, Sven Erik ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

endothelin 1; endothelin converting enzyme; hyperoxia; regulation; retinal hemodynamics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME; FLUORESCEIN; OXYGEN; PHOSPHORAMIDON; SARALASIN;

AMBIENT AIR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPEROXIA; MALE; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; RAT; RETINA BLOOD FLOW; VASOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOOD CIRCULATION; BLOOD FLOW VELOCITY; CELLS, CULTURED; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION; GLYCOPEPTIDES; HYPEROXIA; MALE; METALLOENDOPEPTIDASES; PEPTIDES, CYCLIC; PROTEASE INHIBITORS; RATS; RATS, INBRED BN; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; RESPIRATION; RETINAL VESSELS; SARALASIN; VASOCONSTRICTION;

EID: 0029763397     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Brinchmann-Hansen O, Myhre K. The effect of hypoxia on the central light reflex of retinal arteries and veins. Acta Ophthalmol. 1989;67:249-255.
2. Hickam JB, Frayser R. Studies of the retinal circulation in man: Observations on vessel diameter, arterio-venous oxygen difference, and mean circulation time. Circulation. 1966;33:302-316.
3. Riva CE, Grunwald JE, Sinclair SH. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci. 1983;24:47-51.
4. Clermont AC, Brittis MB, Shiba T, McGovern T, King GL, Bursell SE. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci. 1994;35:981-990.
5. Pakola SJ, Grunwald JE. Effects of oxygen and carbon dioxide on human retinal circulation. Invest Ophthalmol Vis Sci. 1993;34:2866-2870.
6. Gidday JM, Park TS. Adenosine-mediated regulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci. 1993;34:2713-2719.
7. Elliott DA, Ong BY, Bruni JE, Bose D. Role of endothelium in hypoxic contraction of canine basilar artery. Br J Pharmacol. 1989;96:949-955.
8. Kwan YW, Wadsworth RM, Kane KA. Effects of hypoxia on the pharmacological responsiveness of isolated coronary artery rings from the sheep. Br J Pharmacol. 1989;96:849-856.
9. Kwan YW, Wadsworth RM, Kane KA. Hypoxia- and endothelium-mediated changes in the pharmacological responsiveness of circumflex coronary artery rings from the sheep. Br J Pharmacol. 1989;96:857-863.
10. Jackson WF, Duling BR. The oxygen sensitivity of hamster cheek pouch arterioles - in vitro and in-situ studies. Circ Res. 1983;53:515-525.
11. Chang AE, Detar R. Oxygen and vascular smooth muscle contraction revisited. Am J Physiol. 1980;7:H716-H718.
12. Detar R, Bohr DF. Oxygen and vascular smooth muscle contraction. Am J Physiol. 1968;214:241-244.
13. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
14. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S. Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett. 1991;293:45-48.
15. McMahon EG, Palomo MA, Moore WM, McDonald JF, Stern MK. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci USA. 1991;88:703-707.
16. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
17. c receptor) from Xenopus laevis dermal melanophores. J Biol Chem. 1993;25:19126-19133.
18. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
19. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992;13:103-108.
20. Takayanagi R, Kitazumi K, Takasaki C, et al. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 1991;282:103-106.
21. Warner TD, Mitchell JA, de Nucci G, Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rats and rabbit. J Cardiovasc Pharmacol. 1989;13(suppl 5):S85-S88.
22. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 1992;186:867-873.
23. McMurdo L, Corder R, Thiemermann C, Vane JR. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol. 1993; 108:557-561.
24. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, Trimble ER. The effect of endothelin 1 on the retinal microvascular pericyte. Microvasc Res. 1992; 43:241-254.
25. Bursell SE, Clermont AC, Oren B, King GL. The in vivo effect of endothelin on retinal circulation in non-diabetic and diabetic rats. Invest Ophthalmol Vis Sci. 1995;36:596-607.
26. MacCumber MW, Jampel HD, Snyder SH. Ocular effects of the endothelins: Abundant peptides in the eye. Arch Ophthalmol. 1991;109:705-709.
27. Nyborg NCB, Prieto D, Benedito S, Nielsen PJ. Endothelin-1-inducedd contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. Invest Ophthalmol Vis Sci. 1991;32:27-31.
28. B receptor agonist. Life Sci. 1993;53:PL111-PL115.
29. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34:3614-3621.
30. Rockwood EJ, Fantes F, Davis EB, Anderson DR. The response of the retinal vasculature to angiotensin. Invest Ophthalmol Vis Sci. 1987;28:676-682.
31. Jan Danser AH, Derkx FHM, Admiraal PJJ, Deinum J, De Jong PTVM, Schalekamp MADH. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci. 1994; 35:1008-1018.
32. Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci. 1987;28:1747-1751.
33. Cummins DR, Bursell SE, Clermont AC, Taggart JJ, King GL. The effect of intravitreal angiotensin II on retinal vascular flow. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:1589.
34. Bursell SE, Clermont AC, Shiba T, King GL. Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Curr Eye Res. 1992;11:287-295.
35. Takagi C, King GL, Clermont AC, Cummins DR, Takagi H, Bursell SE. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an α-glucosidase inhibitor. Curr Eye Res. 1995;14:741-749.
36. A) receptor mediation is involved in the regulation of normal retinal circulation and in hyperoxic retinal regulation. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S134.
37. Hughes A. A schematic eye for rat. Vision Res. 1979;5:406-412.
38. A receptor. Life Sci. 1992;50:247-255.
39. Koyama T, Matsuo N, Shimizu K, et al. Retinal circulation times in quantitative fluorescein angiography. Graefe's Arch Clin Exp Ophthalmol. 1990;228:442-446.
40. Riva CE, Feke GT, Ben-Sira I. Fluorescein dye-dilution technique and retinal circulation. Am J Physiol. 1978;234:H315-H321.
41. Bulpitt CJ, Dollery CT. Estimation of retinal blood flow by measurement of mean circulation time. Cardiovasc Res. 1971;5:406-412.
42. King GL, Goodman S, Buzney S, Moses A, Kahn RC. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1985; 75:1028-1036.
43. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction. Anal Biochem. 1987;162:156-159.
44. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucl Acids Res. 1982;10:7895-7903.
45. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34:3614-3621.
46. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989; 83:1762-1767.
47. Pollock DM, Divish B, Sullivan GM, Shiosaki K, Opgenorth TJ. Effect of an endothelin A receptor antagonist, BQ-123, on pressor responses to endothelin family peptides. J Vasc Res. 1992;29:183. Abstract.
48. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 1993;52:825-834.
49. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarchnoid hemorrhage: A new animal model. Stroke 1985;16:58-64.
50. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: Implications for vascular function. Circulation. 1991; 84:1457-1468.
51. Webb ML, Dickinson KEJ, Delaney CL, et al. The endothelin receptor antagonist, BQ123, inhibits angiotensin II-inducedd contractions in rabbit aorta. Biochem Biophys Res Commun. 1992;185:887-892.
52. Emori T, Hirata Y, Ohta K, et al. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.